No Data
No Data
Solid Biosciences Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
CHARLESTOWN, Mass., July 01, 2024 (GLOBE NEWSWIRE) -- Solid Biosciences Inc. (Nasdaq: SLDB) (the "Company"), a life sciences company developing precision genetic medicines for neuromuscular and card
Solid Biosciences Joins the Russell 3000 Index
CHARLESTOWN, Mass., July 01, 2024 (GLOBE NEWSWIRE) -- Solid Biosciences Inc. (Nasdaq: SLDB), a life sciences company developing precision genetic medicines for neuromuscular and cardiac diseases, to
This Planet Fitness Analyst Turns Bullish; Here Are Top 5 Upgrades For Monday
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings pag
Solid Biosciences Price Target Maintained With a $12.00/Share by Leerink Partners
Solid Biosciences Price Target Maintained With a $12.00/Share by Leerink Partners
Leerink Partners Upgrades Solid Biosciences(SLDB.US) to Buy Rating, Maintains Target Price $12
Leerink Partners analyst Joseph Schwartz upgrades $Solid Biosciences(SLDB.US)$ to a buy rating, and maintains the target price at $12.According to TipRanks data, the analyst has a success rate of 41.0
Express News | Solid Biosciences Inc : Leerink Partners Raises to Outperform From Market Perform